[ad_1]
Aspirin, which is often used to thin the blood, will be evaluated as a possible treatment for COVID-19 in one of the most comprehensive trials looking for potential drugs, Reuters reported, citing Monitor.
All on the topic:
Coronavirus epidemic (COVID-19) 14574
Patients infected with the new coronavirus are at increased risk of blood clots due to an overreaction of platelets that prevent bleeding. Aspirin works against them and can reduce the risk of clots.
“It makes sense that aspirin could be helpful. It’s also safe, it’s inexpensive, and it’s everywhere,” said Peter Hornby, director of tests.
At least 2,000 patients will receive 150 mg of aspirin a day, along with the usual treatment. His condition will be compared to that of 2,000 other patients on standard non-aspirin therapy. The same test will test the action of the antibiotic azithromycin, as well as the Regenerone antibody cocktail.
Novini.bg allows you to follow the latest data on the deadly coronavirus in real time:
All on the topic:
Coronavirus epidemic (COVID-19)
14574
More about the coronavirus
[ad_2]
